Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses

ConclusionSUVN-G3031 was found to be safe and well tolerated in healthy human subjects without any effect of age, gender, and food on the pharmacokinetics and safety profile.Clinical Trials Registration (https://clinicaltrials.gov): NCT04072380 and NCT02342041.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research